Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-12

Clinical Trial Update: Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months

View source ↗

Summary

Clinical trial update examining whether CXCR4 expression in premature infants correlates with an autism diagnosis at 24 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Autism Spectrum Disorder, Complication of Prematurity | Status: COMPLETED